What are the latest content updates?
Last updated on September 08, 2025We have designed this newest release to enhance the user experience which allows for standardizing diagnostic queries in building immunohistochemistry panels.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see this chart.
For information on updates made to ImmunoQuery data please see the below table:
For information on updates made to ImmunoQuery data please see this chart.
The most recent ImmunoQuery content release comprises over 43,600 cases from 98 new references, which have also added 396 unique antibody-diagnosis relationships. You’ll find new IHC data from studies involving common tumor sites such as breast, ovary, and lung, as well as kidney, skin, and other tissues.
The diagnoses from the following organ systems are now completely in WHO format: skin, soft tissue, lung, brain, head and neck, endocrine, gastrointestinal tract, genitourinary tract, breast, hematopoietic and lymphoid tissue, and eye.
In addition, all diagnosis names begin with the tumor site of origin.
- You can query "kidney" in the search box to get the complete list of kidney tumors available in the ImmunoQuery database in WHO nomenclature from which to select.
- If a tumor can originate at multiple sites, the user can query for "Multi-site".
Non-neoplastic counterparts can be queried to a particular tumor, when data is available (eg. an immunohistochemistry panel can be created to compare "Kidney chromophobe renal cell carcinoma" to "Kidney non-neoplastic tissue").
For additional information on updates made to ImmunoQuery data please see this chart.